BioCentury | Jun 8, 1998
Analyst Picks & Changes

Analyst picks & changes

...PathoGenesis Corp. (PGNS), Seattle, Wash. Business: Infectious diseases, Pulmonary SBC Warburg Dillon Read analyst David Webber lowered...
BioCentury | Jun 1, 1998
Finance

But consider the source

...at Furman, which is beefing up its biotech business after luring banker David MacCallum from SBC Warburg...
BioCentury | May 26, 1998
Finance

Froth, not momentum

...Mitch Silber, partner at The Carson Group. "It's like the internet phenomenon comes to biotech." SBC Warburg...
BioCentury | May 4, 1998
Analyst Picks & Changes

Analyst picks & changes

...to $63 million from $57 million. She raised her price target to $45-$50 from $40-$45. SBC Warburg...
BioCentury | Apr 27, 1998
Analyst Picks & Changes

Analyst picks & changes

...Human Genome Sciences Inc. (HGSI), Gaithersburg, Md. Business: Drug discovery SBC Warburg Dillon Read analyst David Webber...
BioCentury | Apr 27, 1998
Analyst Picks & Changes

Analyst picks & changes

...NeXstar Pharmaceuticals Inc. (NXTR), Boulder, Colo. Business: Infectious diseases SBC Warburg Dillon Read analyst David Webber lowered...
BioCentury | Apr 27, 1998
Analyst Picks & Changes

Analyst picks & changes

...Idec Pharmaceuticals Corp. (IDPH), San Diego, Calif. Business: Cancer SBC Warburg Dillon Read analyst David Webber raised...
BioCentury | Apr 20, 1998
Analyst Picks & Changes

Analyst picks & changes

...Triangle Pharmaceuticals Inc. (VIRS), Durham, N.C. Business: Infectious diseases SBC Warburg Dillon Read analyst David Webber raised...
BioCentury | Apr 20, 1998
Analyst Picks & Changes

Analyst picks & changes

...Idec Pharmaceuticals Corp. (IDPH), La Jolla, Calif. Business: Cancer SBC Warburg Dillon Read analyst David Webber said...
BioCentury | Apr 6, 1998
Finance

Analyst picks & changes

...Advanced Tissue Sciences Inc. (ATIS), La Jolla, Calif. Business: Biomaterial/Skin/Wound SBC Warburg Dillon Read analyst David Webber...
Items per page:
1 - 10 of 46
BioCentury | Jun 8, 1998
Analyst Picks & Changes

Analyst picks & changes

...PathoGenesis Corp. (PGNS), Seattle, Wash. Business: Infectious diseases, Pulmonary SBC Warburg Dillon Read analyst David Webber lowered...
BioCentury | Jun 1, 1998
Finance

But consider the source

...at Furman, which is beefing up its biotech business after luring banker David MacCallum from SBC Warburg...
BioCentury | May 26, 1998
Finance

Froth, not momentum

...Mitch Silber, partner at The Carson Group. "It's like the internet phenomenon comes to biotech." SBC Warburg...
BioCentury | May 4, 1998
Analyst Picks & Changes

Analyst picks & changes

...to $63 million from $57 million. She raised her price target to $45-$50 from $40-$45. SBC Warburg...
BioCentury | Apr 27, 1998
Analyst Picks & Changes

Analyst picks & changes

...Human Genome Sciences Inc. (HGSI), Gaithersburg, Md. Business: Drug discovery SBC Warburg Dillon Read analyst David Webber...
BioCentury | Apr 27, 1998
Analyst Picks & Changes

Analyst picks & changes

...NeXstar Pharmaceuticals Inc. (NXTR), Boulder, Colo. Business: Infectious diseases SBC Warburg Dillon Read analyst David Webber lowered...
BioCentury | Apr 27, 1998
Analyst Picks & Changes

Analyst picks & changes

...Idec Pharmaceuticals Corp. (IDPH), San Diego, Calif. Business: Cancer SBC Warburg Dillon Read analyst David Webber raised...
BioCentury | Apr 20, 1998
Analyst Picks & Changes

Analyst picks & changes

...Triangle Pharmaceuticals Inc. (VIRS), Durham, N.C. Business: Infectious diseases SBC Warburg Dillon Read analyst David Webber raised...
BioCentury | Apr 20, 1998
Analyst Picks & Changes

Analyst picks & changes

...Idec Pharmaceuticals Corp. (IDPH), La Jolla, Calif. Business: Cancer SBC Warburg Dillon Read analyst David Webber said...
BioCentury | Apr 6, 1998
Finance

Analyst picks & changes

...Advanced Tissue Sciences Inc. (ATIS), La Jolla, Calif. Business: Biomaterial/Skin/Wound SBC Warburg Dillon Read analyst David Webber...
Items per page:
1 - 10 of 46